Nursing care
Hepatitis C Screening, explained for the bedside and the exam
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Hepatitis C screening is now recommended for every adult at least once in their lifetime, regardless of risk factors, plus annually for people who inject drugs or have other ongoing exposure. Screening starts with an anti-HCV antibody test; a reactive result needs HCV RNA to confirm active infection. Treatment cures most people in eight to twelve weeks.
The idea in one paragraph
Hepatitis C screening used to be risk-based: ask about injection drug use, blood transfusions before 1992, or tattoos from unregulated equipment, then test if the answer was yes. The CDC and USPSTF moved to universal one-time screening for every adult aged 18 and over, because risk-based questioning missed too many infections in people who did not disclose exposure or did not know they had one.
The test itself is a two-step process. An anti-HCV antibody test screens for prior exposure. If that comes back reactive, the lab or clinician orders an HCV RNA test to see whether the virus is still present. Antibodies alone do not confirm active infection — some people clear the virus spontaneously and carry antibodies for life with no virus in their blood.
Why it matters clinically
Hepatitis C is largely asymptomatic in its early years. A patient can carry the virus for a decade with no jaundice, no fatigue that stands out, nothing that would prompt a visit. By the time symptoms appear, cirrhosis or hepatocellular carcinoma may already be underway. Universal screening catches infection before liver damage accumulates.
The other half of the shift is that hepatitis C is now curable. Direct-acting antivirals clear the virus in eight to twelve weeks for the large majority of patients, with minimal side effects compared to the old interferon regimens. A positive screen is no longer a lifelong diagnosis to manage; it is a course of treatment to complete. That changes how you frame the result to a patient — not a chronic illness sentence, but a fixable problem.
How to apply it at the bedside
Order or confirm a one-time anti-HCV screen for any adult patient who has not been tested, regardless of stated risk factors. Document it the same way you would a routine lipid panel or A1c — it belongs in standard adult preventive care now, not in a targeted risk assessment.
If the antibody test is reactive, follow with HCV RNA before telling the patient they have hepatitis C. A reactive antibody with a negative RNA means past exposure and viral clearance, not active infection — conflating the two causes unnecessary distress and sometimes unnecessary treatment referrals. For people with ongoing risk, such as active injection drug use, screen annually rather than relying on the one-time baseline. Refer confirmed active infections to hepatology or a primary care provider comfortable prescribing direct-acting antivirals.
Where students get it wrong
The most common error is treating hepatitis C screening as risk-based, because that is what older textbooks and even some current clinical rotations still teach. On the exam and in practice, the current standard is universal: every adult, once, no risk factor required as a trigger.
The second error is stopping at the antibody test. A reactive antibody is not a diagnosis of active hepatitis C. Students sometimes answer as though a positive screen means the patient has the disease, when the correct next step is confirmatory RNA testing. Watch also for confusing hepatitis C with hepatitis B serology — the two panels are read completely differently, and mixing up anti-HCV with HBsAg or anti-HBs is a frequent slip under exam time pressure.
Worked examples
A 45-year-old comes in for an annual physical with no reported risk factors and no history of testing. The correct nursing action is to recommend and facilitate a one-time anti-HCV screen as part of routine adult care, not to withhold it because the patient denies injection drug use or transfusion history.
A patient's anti-HCV antibody test returns reactive, and the patient asks whether they have hepatitis C. The correct response is to explain that this result means prior exposure, and that a follow-up HCV RNA test is needed to confirm whether the virus is currently active before anything further is said about diagnosis or treatment.
How the exam tests it
NCLEX questions on this topic often present an adult patient with no obvious risk factors and ask which screening test should be recommended, testing whether you know screening is now universal rather than risk-triggered. Expect a distractor option that limits screening to patients with a specific exposure history — that answer reflects outdated practice.
Other items test the antibody-versus-RNA distinction directly, giving a reactive antibody result and asking for the next nursing action or patient teaching point. The correct answer is confirmatory RNA testing, not immediate referral for treatment or a statement that the patient definitely has active hepatitis C.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our health promotion practice questions are the closest set to what this page covers.
One question from the health promotion set
A client at 30 weeks' gestation reports a headache that will not resolve, blurred vision, and swelling of the hands. Blood pressure is 158/104 mm Hg. Which action should the nurse take first?
Rationale
Headache that will not resolve, visual changes, and a blood pressure of 158/104 after 20 weeks are severe features of preeclampsia — the client is at risk of seizing. Notify and prepare for magnesium sulfate, which is given for seizure prophylaxis rather than for the blood pressure itself. Resting and rechecking in an hour delays treatment, and a urine culture answers a different question entirely.
Answer: B
Common questions
Does everyone really need a hepatitis C test even with no risk factors?
Yes. Current CDC and USPSTF guidance recommends one-time hepatitis C screening for all adults aged 18 and older, regardless of reported risk factors. This replaced the older risk-based approach because it missed too many undiagnosed infections.
What does a reactive anti-HCV antibody test actually mean?
It means the person was exposed to hepatitis C at some point and developed antibodies. It does not confirm active infection on its own — an HCV RNA test is needed to determine whether the virus is currently present in the blood.
How long does hepatitis C treatment take?
Most patients clear the virus with direct-acting antiviral therapy in eight to twelve weeks. Cure rates are high, and side effects are far milder than older interferon-based regimens.
Who needs more frequent screening than the one-time baseline?
People with ongoing exposure risk, such as active injection drug use, should be screened annually rather than relying on a single lifetime test. Pregnant women are also screened during each pregnancy.